Skip to main content

Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction

  • Chapter
Immunoneurology

Summary

Neurologic complications of systemic lupus erythematous (neuro-SLE) are common. The most frequent manifestations of neuro-SLE are seizures, encephalopathy, and behavioral changes, but a wide variety of other neurologic abnormalities affecting the central and peripheral nervous system and muscle also occur. Although the prevalence of neuro-SLE is high, the diversity of clinical presentations, the multiple potential etiologies, and the absence of sensitive and specific diagnostic tests render diagnosis difficult. Recent advances in understanding mechanisms of neuronal dysfunction combined with advances in imaging techniques, including functional imaging, should help in diagnosis and management. The mechanisms of neurologic injury can be divided into three broad categories. First, neuronal dysfunction may result from direct effects of the immune system on brain cells such as autoantibody binding to cell surface, immune complex deposition with secondary inflammation, and effects of cytokines. Second, immune- mediated injury to supportive structures such as the vasculature may also affect the nervous system by producing ischemia. Finally, the neuraxis may be affected by any one of several immune and non- immune effects of infection, toxins, and metabolic disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alarcon-Segovia D, Cabral AR (1994) Antiphospholipid antibodies. Where do they come from? Where do they go? J Rheumatol 21:982

    PubMed  CAS  Google Scholar 

  2. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez-Pacheco L, Cabiedes J, Fernandez L, Ponce De Lion S (1989) Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 68:353

    PubMed  CAS  Google Scholar 

  3. Alarcon-Segovia D, Perez-Vazquez ME, Villa AR, Drenkard C, Cabiedes J (1992) Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 21:275

    Article  PubMed  CAS  Google Scholar 

  4. Al-Janadi M, Raziuddin S (1993) B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus. J Rheumatol 20:1885

    PubMed  CAS  Google Scholar 

  5. Alexander EL, Murphy ED, Roths JB, Alexander GE (1983) Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann Neurol 14:242

    Article  PubMed  CAS  Google Scholar 

  6. Argenbright LW, Barton RW (1992) Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo. J Clin Invest 89:259

    Article  PubMed  CAS  Google Scholar 

  7. Bankhurst AD (1987) Interferons and systemic lupus erythematosus. J Rheumatol [Suppl 13] 14:63

    Google Scholar 

  8. Beer MC de, Kindy MS, Lane WS, Beer FC de (1994) Mouse serum amyloid A protein (SAA5) structure and expression. J Biol Chem 269:4661

    PubMed  Google Scholar 

  9. Belmont HM, Buyon J, Giorno R, Abramson S (1994) Up-regulation of endothelial cell adhestion molecules characterizes disease activity in systemic lupus erythematosus. Arthritis Rheum 37:376

    Article  PubMed  CAS  Google Scholar 

  10. Berden JHM, Hang L, McConahey PJ, Dixon FJ (1983) Analysis of vascular lesions in murine SLE. J Immunol 130:1699

    PubMed  CAS  Google Scholar 

  11. Besedovsky HO, DelRey AE, Sorkin E (1985) Immune-neuroendocrine interactions. J Immunol 135:750s

    PubMed  CAS  Google Scholar 

  12. Besedovsky HO, DelRey A, Sorkin E, Dinarello CA (1986) Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652

    Article  PubMed  CAS  Google Scholar 

  13. Bevilacqua MP, Pober JS, Majeau GR, Cotran RS, Gimbrone MA Jr (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 160:618

    Article  PubMed  CAS  Google Scholar 

  14. Bluestein HG (1978) Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 75:3965

    Article  PubMed  CAS  Google Scholar 

  15. Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265

    Article  PubMed  CAS  Google Scholar 

  16. Boros P, Odin JA, Chen J, Unkeless JC (1994) Specificity and class distribution of FcγR-specific autoantibodies in patients with autoimmune disease. J Immunol 152:302

    PubMed  CAS  Google Scholar 

  17. Boyer RS, Sun NCJ, Verity A, Nies KM, Louie JS (1980) Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus. J Rheumatol 7:645

    PubMed  CAS  Google Scholar 

  18. Brenner BM, Troy JL, Ballermann BJ (1989) Endothelium-dependent vascular responses. J Clin Invest 84:1373

    Article  PubMed  CAS  Google Scholar 

  19. Cines DB (1989) Disorders associated with antibodies to endothelial cells. Rev Infect Dis 2 [Suppl 4]:S705

    Article  Google Scholar 

  20. Collins DN, Oppenheim IA, Edwards MR (1971) Cryptococcosis associated with systemic lupus erythematosus. Arch Pathol Lab Med 91:78

    CAS  Google Scholar 

  21. Combardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum 35:630

    Article  Google Scholar 

  22. DeHoratius RJ, Pillarisetty R, Messner R, Talal N (1975) Anti-nucleic acid antibodies in systemic lupus erythematosus patients and their families: incidence and correlation with lymphocytotoxic antibodies. J Clin Invest 56:1149

    Article  PubMed  CAS  Google Scholar 

  23. Deleze M, Mintz G, CarmenMejia M (1985) Toxoplasma gondii encephalitis in systemic lupus erythematosus: a neglected cause of treatable nervous system infection. J Rheumatol 12:5:994

    Google Scholar 

  24. Denburg SD, Carbotte RM, Denburg J A (1987) Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol 9:323

    Article  PubMed  CAS  Google Scholar 

  25. Denenberg VH, Sherman GF, Morrison L, Schrott LM, Waters NS, Rosen GD, Behan PO, Galaburda AM (1992) Behavior, ectopias and immunity in BD/DB reciprocal crosses. Brain Res 571:323

    Article  PubMed  CAS  Google Scholar 

  26. Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze M, Chang AE, Rosenstein D, Rosenberg SA (1987) The neuropsychiatric effects of treatment with interleukin-2 and lymphokineactivated killer cells. Ann Intern Med 107:293

    PubMed  CAS  Google Scholar 

  27. Derksen RHWM, van Dam AP, Meyling FHJG, Bijlsma JWJ, Smeenk RJT (1990) A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis. Ann Rheum Dis 49:779

    Article  PubMed  CAS  Google Scholar 

  28. De Simoni MG, Sironi M, De Luigi A, Manfridi A, antovani A, Ghezzi P (1990) Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. J Exp Med 171:1773

    Article  PubMed  Google Scholar 

  29. Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol 23:380

    Article  PubMed  CAS  Google Scholar 

  30. Dixon FJ (1987) Basic elements of murine systemic lupus erythematosus. J Rheumatol 14:3

    Google Scholar 

  31. Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 8:212

    Article  PubMed  CAS  Google Scholar 

  32. Fields RA, Sibbitt WL, Toubbeh H, Bankhurst AD (1990) Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis 49:114

    Article  PubMed  CAS  Google Scholar 

  33. Fronek Z, Timmerman LA, Alper CA, et.al. (1990) Major histocompatibilty complex genes and susceptibility to systemc lupus erythematosus. Arthritis Rheum 33:1542

    Article  PubMed  CAS  Google Scholar 

  34. Futrell N, Millikan C (1989) Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 20:584

    Article  Google Scholar 

  35. Gahring LC, Weigle WO (1990) The regulatory effects of cytokines on the induction of a peripheral immunologic tolerance in mice. J Immunol 145:1318

    PubMed  CAS  Google Scholar 

  36. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J (1968) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 319:817

    Article  Google Scholar 

  37. Gibbons GH, Dzau VJ (1994) The emerging concept of vascular remodeling. N Engl J Med 330:1431

    Article  PubMed  CAS  Google Scholar 

  38. Golan DT (1988) Exposure to UV light in the pathogenesis of systemic lupus erythematosus(SLE). 24:360

    Google Scholar 

  39. Golombek SJ, Elkon KB (1986) Variety of auto-antibodies in the cerebrospinal fluid of lupus patients. Arthritis Rheum 29:S8

    Article  Google Scholar 

  40. Golombek SJ, Graus F, Elkon KB (1986) Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum 29:1090

    Article  PubMed  CAS  Google Scholar 

  41. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612

    Article  PubMed  CAS  Google Scholar 

  42. Gutierrez-Ramos JC, Andreu JL, Alboran IM de, Rodriguez J, Leonardo E, Kroemer G, Marcos MAR, Martinez-AC (1990) Insights into autoimmunity: from classical models to current perspectives. Immunol Rev 118:73

    PubMed  CAS  Google Scholar 

  43. Hahn BH, Ebling FM (1984) A public idiotype determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus-prone strains. J Immunol 133:3015

    PubMed  CAS  Google Scholar 

  44. Hammad A, Tsukada Y, Torre N (1992) Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheum Dis 51:550

    Article  PubMed  CAS  Google Scholar 

  45. Handwerger B, Rus V, daSilva L, Via C (1994) The role of cyotkines in the immunopathogenesis of lupus. Springer Seminars in Immunopathology 16:153–180

    Article  PubMed  CAS  Google Scholar 

  46. Hanly JG, Rajaraman S, Behmann S, Denburg JA (1988) A novel neuronal antigen identified by sera from patients with system lupus erythematosus. Arthritis Rheum 31:1492

    Article  PubMed  CAS  Google Scholar 

  47. Hanly JG, Walsh NMG, Sangalang V (1992) Brain pathology in systemic lupus erythematosus. J Rheumatol 19:732

    PubMed  CAS  Google Scholar 

  48. Hanly JG, Walsh NM, Fisk JD, Eastwood B, Hong C, Sherwood G, Jones JV, Jones E, Elkon K (1993) Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 32:291

    Article  PubMed  CAS  Google Scholar 

  49. Hart MN, Zsuzsanna F, Waldschmidt M, Sandor M (1990) Lymphocyte interacting adhesion molecules on brain microvascular cells. Mol Immunol 27:1355

    Article  PubMed  CAS  Google Scholar 

  50. Hay EM, Isenberg DA (1993) Autoantibodies in central nervous system lupus. Br J Rheumatol 32:329

    Article  PubMed  CAS  Google Scholar 

  51. Hay EM, Huddy A, Black D, Mbaya P, Tomenson B, Bernstein RM, Holt PJL, Creed F (1994) A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis 53:298

    Article  PubMed  CAS  Google Scholar 

  52. Hellerstein MK, Meydani SN, Meydani M, Wu K, Dinarello CA (1989) Interleukin-1-induced anorexia in the rat. Influence of prostaglandins. J Clin Invest 84:228

    Article  PubMed  CAS  Google Scholar 

  53. Hess DC, Taormina M, Thompson J, Sethi D, Diamond B, Rao R, Chamberlain CR, Feldman DS (1993) Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 20:610

    PubMed  CAS  Google Scholar 

  54. Hirohata S, Miyamoto T (1990) Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum 33:644

    Article  PubMed  CAS  Google Scholar 

  55. Hirohata S, Hirose S, Miyamoto T (1985) Cerebrospinal fluid IgM, IgA, IgG indexes in systemic lupus erythematosus. Arch Intern Med 145:1843

    Article  PubMed  CAS  Google Scholar 

  56. How A, Dent PB, Liao S-K, Denburg JA (1985) Antineuronal antibodies in neuropsychiatry system lupus erythematosus. Arthritis Rheum 28:789

    Article  PubMed  CAS  Google Scholar 

  57. Hoyle C, Ewing DJ, Parker AC (1985) Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis 44:420

    Article  PubMed  CAS  Google Scholar 

  58. Isenberg DA, Snaith ML (1981) Muscle disease in systemic lupus erythematosus: a study of its nature, frequency and cause. J Rheumatol 8:917

    Google Scholar 

  59. Johnson RT, Richardson EP (1968) The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 47:337

    Article  PubMed  CAS  Google Scholar 

  60. Jyonouchi H, Kincade PW, Good RA, Fernandes G (1981) Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 micel. J Immunol 127:1232

    PubMed  CAS  Google Scholar 

  61. Kaell AT, Shetty M, Lee BCP, Lockshin MD (1986) The diversity of neurologic events in systemic lupus erythematosus. Arch Neurol 43:273

    PubMed  CAS  Google Scholar 

  62. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M (1990) Interleukin IB inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323

    Article  PubMed  CAS  Google Scholar 

  63. Keeffe EB, Bardama EJ, Harbeck RJ, Pirofsky B, Carr RI (1974) Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. Ann Intern Med 80:58

    PubMed  CAS  Google Scholar 

  64. Khamashta MA, Hughes GRV (1993) Antiphospholipid antibodies and valve disease in patients with systemic lupus erythematosus. J Am Coll Cardiol 22:1268

    Article  Google Scholar 

  65. Khamashta MA, Harris EN, Gharavi AE, Derue G, Gil A, Vazquez JJ, Hughes GRV (1988) Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 47:849

    Article  PubMed  CAS  Google Scholar 

  66. Khokher MA, Dandona P, Janah S, Coulston GL (1981) Insulin-like stimulatory effect of human immunoglobulin G on adipocyte lipogenesis. Diabetes 30:1068

    Article  PubMed  CAS  Google Scholar 

  67. Kitagawa Y, Gotoh F, Koto A, Okayasu H (1990) Stroke in systemic lupus erythematosus. Stroke 21:1533

    Article  PubMed  CAS  Google Scholar 

  68. Koren E, Reichlin MW, Koscec M, Fugat RD, Reichlin M (1993) Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest 89:1236

    Article  Google Scholar 

  69. Lee P, Urowitz MB, Bookman AAM, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA (1977) Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis -and prognosis. Q J Med 46:1

    PubMed  CAS  Google Scholar 

  70. Lerner MR, Boyle JA, Mount SM, Wolin SL, Steitz JA (1980) Are snRNPs involved in splicing? Nature 283:220

    Article  PubMed  CAS  Google Scholar 

  71. Linker-Israeli M (1992) Cytokine abnormalities in human lupus. Clin Immunol Immunopathol 63:10

    Article  PubMed  CAS  Google Scholar 

  72. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-chen T, Klinenberg JR (1991) Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 147:117

    PubMed  CAS  Google Scholar 

  73. Lo S, Salem HH, Howard MA, Oldmeadow MJ, Firkin B (1990) Studies of natural anticoagulant proteins and anticardiolipin antibodies in patients with the lupus anticoagulant. Br J Haematol 76:380

    Article  PubMed  CAS  Google Scholar 

  74. Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA (1990) Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 49:249

    Article  PubMed  CAS  Google Scholar 

  75. Lotz M, Vaughan JH, Carson DA (1988) Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241:1218

    Article  PubMed  CAS  Google Scholar 

  76. Love PE, Santoro SA (1990) Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682

    PubMed  CAS  Google Scholar 

  77. Male D, Pryce G, Hughes C, Lantos P (1990) Lymphocyte migration into brain modelled in vitro: control by lymphocyte actication, cytokines, and antigen. Cell Immunol 127:1

    Article  PubMed  CAS  Google Scholar 

  78. McClain C, Cohen D, Phillips R, Ott L, Young B (1993) Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 118:225

    Google Scholar 

  79. Merino R, Iwamoto M, Fossati L, Izui S (1993) Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice. J Immunol 151:6509

    PubMed  CAS  Google Scholar 

  80. Michet CJ, McKenna CH, Elveback LR, Kaslow RA, Kurland LT (1985) Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 60:105

    PubMed  Google Scholar 

  81. Miguel EC, Pereira RMR, Pereira CADB, Baer L, Gomes RE, Sa LCF de, Hirsch R, Barros NG de, Navarro JM de, Gentil V (1994) Psychiatric manifestations of systemic lupus erythematosus: clinical features, symptoms, and signs of central nervous system activity in 43 patients. Medicine 73:224

    Article  PubMed  CAS  Google Scholar 

  82. Mitchell SR, Nguyen PQ, Katz P (1990) Increased risk of neisserial infections in systemic lupus erythematosus. Semin Arthritis Rheum 20:174

    Article  PubMed  CAS  Google Scholar 

  83. Moore PM (1990) Immunoglobulin binding to neuronal cell surface epitopes in murine systemic lupus erythematosus. J Neuroimmunol 30:101

    Article  PubMed  CAS  Google Scholar 

  84. Moore PM (1992) Evidence for bound antineuronal antibodies in brains of NZB/w mice. J Neuroimmunol 38:147

    Article  PubMed  CAS  Google Scholar 

  85. Moore PM, Joshi I, Ghanekar SM (1994) Affinity isolation of neuron reactive antibodies in MRL/lpr Mice. J Neurosci Res 39:140

    Article  PubMed  CAS  Google Scholar 

  86. Mountz JD, Wu J, Cheng J, Zhou T (1994) Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 37:1415

    CAS  Google Scholar 

  87. Nachman RL, Silverstein R (1993) Hypercoagulable states. Ann Intern Med 119:819

    PubMed  CAS  Google Scholar 

  88. Narendran A, Hoffman SA (1989) Characterization of brain-reactive autoantibodies in murine models of systemic lupus erythematosus. J Neuroimmunol 24:113

    Article  PubMed  CAS  Google Scholar 

  89. Pisetsky DS, Grudier JP, Gilkeson GS (1990) A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. Arthritis Rheum 33:153

    Article  PubMed  CAS  Google Scholar 

  90. Reichlin S (1993) Neuroendocrine-immune interactions. N Engl J Med 329:1246

    Article  PubMed  CAS  Google Scholar 

  91. Reidenberg MM (1983) Aromatic amines and the pathogenesis of lupus erythmatosus. Am J Med 75:1037

    Article  PubMed  CAS  Google Scholar 

  92. Ritchlin CT, Chabot RJ, Alper K, Buyon J, Belmont HM, Roubey R, Abramson SB (1992) Quantitative electroencephalography. Arthritis Rheum 35:1330

    PubMed  CAS  Google Scholar 

  93. Rudh I, Olsson T, Lindstrom F, Skogh T (1985) Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus. J Neurol 48:807

    Google Scholar 

  94. Rudick RA, Eskin TA (1983) Neuropathological features of a lupus like disorder in autoimmune mice. Ann Neurobiol 14:325

    Article  CAS  Google Scholar 

  95. Schneebaum AB, Singleton JD, Sterling G, West MD, Blodgett JK, Allen LG, Cheronis JC, Kotzin BL (1991) Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 90:54

    Article  PubMed  CAS  Google Scholar 

  96. Schwartz MM, Roberts JL (1983) Membranous and vascular choroidopathy: two patterns of immune deposits in systemic lupus erythematosus. Clin Immunol Immunopathol 29:369

    Article  PubMed  CAS  Google Scholar 

  97. Schwartz RH (1989) Acquisition of immunologic self-tolerance. Cell 57:1073

    Article  PubMed  CAS  Google Scholar 

  98. Schwartz RS (1986) Anti-DNA antibodies and the problem of autoimmunity. Cell Immunol 99:38

    Article  PubMed  CAS  Google Scholar 

  99. Seibold JR, Buckingham RB, Medsger TA Jr, Kelly RH (1982) Cerebrospinal fluid immune complexes in systemic lupus erythematosus involving the central nervous system. Semin Arthritis Rheum 12:68

    Article  PubMed  CAS  Google Scholar 

  100. Sergent JS, Lockshin MD, Klempner MS, Lipsky BA (1975) Central nervous system disease in systemic lupus erythematosus. Am J Med 58:644

    Article  PubMed  CAS  Google Scholar 

  101. Shen HH, Winchester RJ (1986) Susceptibility genetics of systemic lupus erythematosus. Springer Semin Immunopathol 9:143

    Article  PubMed  CAS  Google Scholar 

  102. Sibbitt WL Jr, Froelich CJ, Bankhurst AD (1984) Interferon-regulation of lymphocyte function in systemic lupus erythematosus. Clin Immunol Immunopathol 32:70

    Article  PubMed  Google Scholar 

  103. Sibley JT, Olszynski WP, Decoteau WE, Sundaram MB (1992) The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol 19:47

    PubMed  CAS  Google Scholar 

  104. Sieving RR, Kauffman CA, Watanakunakorn C (1975) Deep fungal infection in systemic lupus erythematosus-three cases reported, literature reviewed. J Rheumatol 2:61

    PubMed  CAS  Google Scholar 

  105. Simon J, Simon O (1975) Effect of passive transfer of anti-brain antibodies to a normal recipient. Exp Neurol 47:523

    Article  PubMed  CAS  Google Scholar 

  106. Singh RR, Prasad K, Kumar A, Misra A, Padmakumar K, Malaviya AN (1988) Cerebellar ataxia in systemic lupus erythematosus: three case reports. Ann Rheum Dis 47:954

    Article  PubMed  CAS  Google Scholar 

  107. Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Kreig AM (1991) Systemic lupus erythematosus. Ann Intern Med 115:548

    PubMed  CAS  Google Scholar 

  108. Sternberg EM, Chrousos GP, Wilder RL, Gold PW (1992) The stress response and the regulation of inflammatory disease. Ann Intern Med 117:854

    PubMed  CAS  Google Scholar 

  109. Stevens MB (1986) Systemic lupus erythematosus clinical issues. Springer Semin Immunopathol 9:251

    Article  PubMed  CAS  Google Scholar 

  110. Stott DI (1990) Lessons about autoantibody specificity in systemic lupus erythematosus from animal models (editorial review). Clin Exp Immunol 81:1

    Article  PubMed  CAS  Google Scholar 

  111. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271

    Article  PubMed  CAS  Google Scholar 

  112. Tanaka Y, Saito K, Shirakawa F, Ota T, Suzuki H, Eto S, Yamashita U (1988) Production of B cellstimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 141:3043

    PubMed  CAS  Google Scholar 

  113. Tanaka Y, Shirakawa F, Ota T, Suzuki H, Eto S, Yamashita U (1988) Mechanism of spontaneous activation of B cells in patients with systemic lupus erythematosus. J Immunol 140:761

    PubMed  CAS  Google Scholar 

  114. Taylor SI, Grunberger G, Marcus-Samuels B, Underhill LH, Dons RF, Ryan J, Roddam RF, Rupe CE, Gorden P (1982) Hypoglycemia associated with antibodies to the insulin receptor. N Engl J Med 307:1422

    Article  PubMed  CAS  Google Scholar 

  115. Teh L, Isenberg DA (1994) Antiribosomal protein antibodies in systemic lupus erythematosus. Arthritis Rheum 37:307

    Article  PubMed  CAS  Google Scholar 

  116. Teh LS, Bedwell AE, Isenberg DA, Gordon C, Emery P, Charles PJ, Harper M, Amos N, Williams BD (1992) Antibodies to protein P in systemic lupus erythmatosus. Ann Rheum Dis 51:489

    Article  PubMed  CAS  Google Scholar 

  117. Teh LS, Hay EM, Amos N, Black D, Huddy A, Creed F, Bernstein RM, Holt PS, Williams BD (1993) Anti-P antibodies are associated with psychiatric and focal cerebral disorders in patients with systemic lupus erythematosus. Br J Rheumatol 32:287

    Article  PubMed  CAS  Google Scholar 

  118. Theofilopoulos AN, Dixon FJ (1981) Etiopathogenesis of murine SLE. Immunol Rev 55:179

    Article  PubMed  CAS  Google Scholar 

  119. Venter JC (1982) Monocolonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: The future of receptor research. J Molec Cell Immunol 14:687

    CAS  Google Scholar 

  120. Via CS, Tsokos GC, Bermas B, Clerici M, Shearer GM (1993) T cell-antigen-presenting cell interactions in human systemic lupus erythematosus. J Immunol 151:3914

    PubMed  CAS  Google Scholar 

  121. Vidailhet M, Piette J, Wechsler B, Bousser MG, Brunet P (1990) Cerebral venous thrombosis in systemic lupus erythematosus. Stroke 21:1226

    Article  PubMed  CAS  Google Scholar 

  122. Winfield JB, Mimura T (1992) Pathogenetic significance of anti-lymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 63:13

    Article  PubMed  CAS  Google Scholar 

  123. Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA HI, Koffler D (1983) Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74:837

    Article  PubMed  CAS  Google Scholar 

  124. Wysenbeek A J, Leibovici L, Zoldan J (1990) Acute central nervous system complications after pulse steroid therapy in patients with systemic lupus erythematosus. J Rheumatol 17:1695

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Moore, P.M., Lisak, R.P. (1996). Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction. In: Chofflon, M., Steinman, L. (eds) Immunoneurology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-61191-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-61191-9_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64741-3

  • Online ISBN: 978-3-642-61191-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics